Last update 02 Mar 2026

68Ga-NYM032

Overview

Basic Info

Drug Type
Small molecule drug, Diagnostic radiopharmaceuticals
Synonyms
68Ga-NY108, 68Ga-NYM032, NY108
Target
PSMA
Action
inhibitors, enhancers
Mechanism
PSMA inhibitors(Prostate-specific membrane antigen inhibitors), PET imaging(Positron-emission tomography enhancers)
Therapeutic Areas
NeoplasmsUrogenital Diseases
Active Indication
Adenocarcinoma of prostateLocalized Prostate CarcinomaMetastatic Prostate Carcinoma+ [1]
Inactive Indication-
Originator Organization
Norroy Bioscience Co., LTD
Active Organization
Norroy Bioscience Co., LTDAffiliated Hospital of Jiangnan University
Inactive Organization-
License Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

4
Clinical Trials associated with 68Ga-NYM032
NCT06389695
/ CompletedPhase 1/2
Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of a Single Dose of Gallium [68Ga]-NYM032 Injection Prepared by Kit for the Preparation of the 68Ga-NYM032 Injection in Patients With Prostate Cancer
CTR20241621
/ CompletedPhase 1/2
镓[68Ga]-NYM032注射液在健康受试者、前列腺癌患者体内的药代动力学、生物分布、辐射剂量和安全性研究
[Translation] Study on the pharmacokinetics, biodistribution, radiation dose and safety of gallium [68Ga]-NYM032 injection in healthy subjects and prostate cancer patients
NCT05623878
/ RecruitingEarly Phase 1IIT
68Ga-labeled NY108 PET Imaging in Patients
100 Clinical Results associated with 68Ga-NYM032
Login to view more data
100 Translational Medicine associated with 68Ga-NYM032
Login to view more data
100 Patents (Medical) associated with 68Ga-NYM032
Login to view more data
100 Deals associated with 68Ga-NYM032
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Adenocarcinoma of prostatePhase 3
China
Norroy Bioscience Co., LTD
28 Feb 2026
Localized Prostate CarcinomaPhase 3
China
Norroy Bioscience Co., LTD
28 Feb 2026
Metastatic Prostate CarcinomaPhase 2
China
Norroy Bioscience Co., LTD
04 Jun 2024
Prostatic CancerPhase 1
China
Affiliated Hospital of Jiangnan University
04 Jan 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT06389695 (Phase Ia study, ASCO2025)
Phase 1
Prostatic Cancer
9
amseqltvcb(dqgfficjtg) = djogxqdltn xypnfdaoiq (caivxxfxmr )
View more
Positive
30 May 2025
amseqltvcb(dqgfficjtg) = pctntoiuqo xypnfdaoiq (caivxxfxmr )
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free